Novel Challenges and Advances in Respiratory Diseases
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: 15 November 2024 | Viewed by 53
Special Issue Editor
Interests: respiratory medicine; pathophysiology; respiratory infections; bronchoscopy; viruses; COVID-19; biostatistics
Special Issue Information
Dear Colleagues,
This Special Issue, entitled “Novel Challenges and Advances in Respiratory Diseases”, aims to offer a comprehensive exploration of the latest research and advancements in the field of respiratory medicine. With a particular focus on innovative approaches, breakthrough treatments, and cutting-edge technologies, this issue aims to shed light on the diverse spectrum of respiratory conditions and their management strategies. From investigating novel therapeutic interventions to elucidating the underlying mechanisms of respiratory diseases, the articles in this Special Issue provide valuable insights into understanding, diagnosing, and treating various pulmonary disorders. Additionally, given the unprecedented challenges posed by emerging pathogens like COVID-19, this issue also addresses the impact of such global health crises on respiratory health and healthcare systems. By covering topics such as immunotherapy, precision medicine, respiratory infections, and airway diseases, this Special Issue serves as a valuable resource for researchers, clinicians, and policymakers striving to advance the field of respiratory medicine and improve patient outcomes.
Dr. Vasiliki E. Georgakopoulou
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- respiratory diseases
- pulmonary disorders
- lung health
- novel therapies
- diagnostic advancements
- COVID-19 impact
- immunotherapy
- respiratory infections
- airway diseases
- precision medicine
